A placebo-controlled double-blind randomized cross over pilot study of the efficacy and tolerability if incobotulinum toxin A (Xeomin) as a treatment for focal task-specific dystonia of the musician's hand

Brief description of study

The purpose of this study is to investigate the effects of the drug Incobotulinum toxin A (BoNT; Xeomin) on musicians that are diagnosed with dystonia of the hand. Dystonia of the hand causes hand spasms that prevent the musician from playing his/her instrument. Musician’s dystonia typically affects highly trained musicians and up to 1% (or 1 out of 100) of professional musicians. You can participate in this research if you have been diagnosed with focal task-specific dystonia of one or both hands and you are a musician.


Clinical Study Identifier: s17-01265
ClinicalTrials.gov Identifier: NCT02107261
Principal Investigator: Steven J. Frucht
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.